ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 210717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 210717; 2) Community: the network communities that were significantly associated with the response to NSC 210717; 3) Molecule: the relationships between components within communities and NSC 210717; 4) MDR: the compounds that were significantly associated with the NSC 210717.

NSC Compound Enrichment Correlation
NSC 610459 Camptothecin Derivative 0.0287337488682928 0.39445049
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0287337488682928 0.074298194
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0287337488682928 0.17745615
NSC 642954 Null 0.0287337488682928 0.40406384
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0287337488682928 0.40889124
NSC 668523 N,N-bis(2-chloropropyl)-N-methylammonium chloride 0.0287337488682928 0.45419176
NSC 671122 Null 0.0287337488682928 0.075074016
NSC 673452 Null 0.0287337488682928 0.33785297
NSC 681635 Camptothecin Derivative 0.0287337488682928 0.43130704
NSC 681639 Camptothecin Derivative 0.0287337488682928 0.49074852
Total:32  Current:18    [First] [Prev] [Next] [Last]